Prevalence and Incidence of HIV in a Rural Community-Based HIV Vaccine Preparedness Cohort in Masaka, Uganda
Open Access
- 3 June 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (6), e20684
- https://doi.org/10.1371/journal.pone.0020684
Abstract
Local HIV epidemiology data are critical in determining the suitability of a population for HIV vaccine efficacy trials. The objective of this study was to estimate the prevalence and incidence of, and determine risk factors for HIV transmission in a rural community-based HIV vaccine preparedness cohort in Masaka, Uganda. Between February and July 2004, we conducted a house-to-house HIV sero-prevalence survey among consenting individuals aged 18–60 years. Participants were interviewed, counseled and asked to provide blood for HIV testing. We then enrolled the HIV uninfected participants in a 2-year HIV sero-incidence study. Medical evaluations, HIV counseling and testing, and sample collection for laboratory analysis were done quarterly. Sexual risk behaviour data was collected every 6 months. The HIV point prevalence was 11.2%, and was higher among women than men (12.9% vs. 8.6%, P = 0.007). Risk factors associated with prevalent HIV infection for men were age <25 years (aOR = 0.05, 95% CI 0.01–0.35) and reported genital ulcer disease in the past year (aOR = 2.17, 95% CI 1.23–3.83). Among women, being unmarried (aOR = 2.59, 95% CI 1.75–3.83) and reported genital ulcer disease in the past year (aOR = 2.40, 95% CI 1.64–3.51) were associated with prevalent HIV infection. Twenty-one seroconversions were recorded over 2025.8 person-years, an annual HIV incidence of 1.04% (95% CI: 0.68–1.59). The only significant risk factor for incident HIV infection was being unmarried (aRR = 3.44, 95% CI 1.43–8.28). Cohort retention after 2 years was 87%. We found a high prevalence but low incidence of HIV in this cohort. HIV vaccine efficacy trials in this population may not be feasible due to the large sample sizes that would be required. HIV vaccine preparatory efforts in this setting should include identification of higher risk populations.Keywords
This publication has 19 references indexed in Scilit:
- Documenting the SARS epidemic in mainland ChinaTropical Medicine & International Health, 2009
- HIV Prevalence and Associated Risk Factors among Individuals Aged 13-34 Years in Rural Western KenyaPLOS ONE, 2009
- Is sexual risk taking behaviour changing in rural south-west Uganda? Behaviour trends in a rural population cohort 1993-2006Sexually Transmitted Infections, 2009
- Willingness to participate in preventive HIV vaccine trials in a community‐based cohort in south western UgandaTropical Medicine & International Health, 2009
- Epidemiology of HIV-1 Infection in Agricultural Plantation Residents in Kericho, KenyaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Preparing for phase II/III HIV vaccine trials in AfricaMicrobes and Infection, 2005
- Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1The New England Journal of Medicine, 2000
- The role of conceptual frameworks in epidemiological analysis: a hierarchical approach.International Journal of Epidemiology, 1997
- The Causal Role for Genital Ulcer Disease as a Risk Factor for Transmission of Human Immunodeficiency VirusSexually Transmitted Diseases, 1996
- Migration and HIV-1 seroprevalence in a rural Ugandan populationAIDS, 1995